Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Antimicrobial Agents and Chemotherapy|June 7, 2017
Different Resistance Mechanisms for Cadazolid and Linezolid in Clostridium difficile Found by Whole-Genome Sequencing AnalysisPatrick Caspers, Hans H Locher, Philippe Pfaff, et al.
Organic Letters|February 14, 2006
Potent algicides based on the cyanobacterial alkaloid nostocarbolineJudith F Blom, Tobias Brütsch, Damien Barbaras, et al.
Antimicrobial Agents and Chemotherapy|October 28, 2015
Cadazolid Does Not Promote Intestinal Colonization of Vancomycin-Resistant Enterococci in MicePeter Seiler, Michel Enderlin-Paput, Philippe Pfaff, et al.
Scientific Reports|April 6, 2019
Structural basis of translation inhibition by cadazolid, a novel quinoxolidinone antibioticAlain Scaiola, Marc Leibundgut, Daniel Boehringer, et al.
Antimicrobial Agents and Chemotherapy|November 27, 2013
Investigations of the mode of action and resistance development of cadazolid, a new antibiotic for treatment of Clostridium difficile infectionsHans H Locher, Patrick Caspers, Thierry Bruyère, et al.
The Journal of Antimicrobial Chemotherapy|February 23, 2020
Antimicrobial activity of POL7306 tested against clinical isolates of Gram-negative bacteria collected worldwideHelio S Sader, Paul R Rhomberg, Leonard R Duncan, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2001
Peptide deformylase as an antibacterial drug target: target validation and resistance developmentC M Apfel, H Locher, S Evers, et al.
Frontiers in Microbiology|August 15, 2020
Identification of Genes Required for Resistance to Peptidomimetic Antibiotics by Transposon SequencingAlessandra Vitale, Gabriella Pessi, Matthias Urfer, et al.
Chemotherapy|August 18, 2010
Dimers of nostocarboline with potent antibacterial activityHans H Locher, Daniel Ritz, Philippe Pfaff, et al.
Frontiers in Neurology|November 8, 2024
The evolution of intractable Ménière's disease: attacks resolve over timeF R Gerritsen, A A Schenck, H Locher, et al.
Pageof 5